James Lovgren Email and Phone Number
James Lovgren work email
- Valid
- Valid
- Valid
- Valid
James Lovgren personal email
- Valid
- Valid
- Valid
James Lovgren phone numbers
I am an accomplished life science executive with a distinguished track record of commercializing disruptive technologies and managing industry-leading global product portfolios in excess of $250M. Businesses under my leadership have benefited from consistent revenue growth, increased profit margins, and expanded market share.My background includes working at startups, growth-stage, and Fortune 150 biotechnology companies, commercializing a diverse range of products and solutions within the biotechnology sector. I am recognized for my strategic thinking, delivering game-changing products, and leading teams to success.As the CEO of Aspiro Therapeutics, I am dedicated to pioneering the development of groundbreaking treatments for obstructive lung diseases. With over a decade of experience in biotech, my focus is on advancing our lead candidate, a CC16 peptidomimetic, through preclinical development with a clear pathway to clinical trials. I am committed to building strategic partnerships, securing funding, and driving our mission to bring life-changing therapies to patients worldwide. Specialties:Executive Leadership, Business Strategy, Product Management, Marketing, Innovation, Venture Capital, Sales Growth Initiatives, Technology Evaluation, Project Management, Customer Relationship Management, Negotiation
Aspiro Therapeutics
View- Website:
- aspirotx.com
- Employees:
- 4
-
Chief Executive Officer And Co-FounderAspiro TherapeuticsUnited States
-
Chief Executive Officer & Co-FounderAspiro Therapeutics Apr 2024 - PresentAspiro Therapeutics is on a mission to revolutionize treatment for obstructive lung diseases by mimicking the protective power of CC16, a natural lung protein vital for healthy breathing. We are focused on developing advanced, disease-modifying therapies that target the underlying mechanisms of conditions like asthma and COPD, going beyond symptom relief to alter the natural course of these diseases.
-
Screening Committee MemberCancer Fund Oct 2023 - PresentPhoenix, Arizona, UsThe Cancer Fund (CF) is the first early-stage impact venture capital fund designed to impact cancer by commercializing promising cancer research for preventions, therapies, cures, and enabling technologies.◆ Advise and counsel on potential Life Science and Healthcare investment opportunities◆ investments range from pre-seed to later stages to manage risk exposure while addressing an array of capital needs -
Venture AdvisorMbx Capital Sep 2020 - PresentNew York City, UsMBX is a venture capital partnership investing in good health, for everyone. At MBX, our investment team focuses on early-stage healthcare, medical device, and biotech companies.◆ Advise and counsel on potential Life Science and Healthcare investment opportunities◆ Seed through Series B investments in life sciences/healthcare startups -
Managing DirectorLovgren Consulting Oct 2023 - PresentResults-driven consultancy focused on delivering tangible outcomes for your life sciences business. Expertise in strategic planning, marketing, product management & commercialization, and business development that drives innovation and growth. Let's collaborate to develop comprehensive strategies, launch impactful products, and propel your business forward. -
Senior Vice President | Global MarketingMaxcyte, Inc. Sep 2021 - Oct 2023Rockville, Maryland, Us(NASDAQ: MXCT) At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today’s processes to innovate tomorrow’s solutions. -
Vice President | Cell TherapyBerkeley Lights, Inc. Sep 2020 - Aug 2021Emeryville, Ca, Us(NASDAQ: BLI) The Opto™ Cell Therapy Development Workflow accelerates the creation of better therapeutics by enabling multiple functional assays to be performed simultaneously on 1000s of individual T cells in a matter of days. Deeply characterize, profile, and map your T cell populations at the single-cell level to directly link behavior to gene expression. -
Senior Director & General Manager | Cell And Gene TherapyThermo Fisher Scientific Jan 2018 - Sep 2020Waltham, Ma, UsDirector, Product Management 2018 - 2019(NYSE: TMO) Bringing a cell or gene therapy to market is a monumental endeavor that requires commitment, dedication, and a lot of science. This work holds the potential to deliver life-changing treatments—Our mission is to help researchers succeed by providing high-quality materials, services, and support to help them translate their cell therapy from discovery to clinical research and commercial manufacturing. -
Consultant / Business Development | Stem Cells & Cell TherapyMinerva Biotechnologies Jun 2016 - Jan 2018Waltham, Ma, UsMinerva Biotechnologies is developing therapies for curing cancers and commercializing core technology that will enable next-generation stem cell therapies. Both flow from Minerva’s fundamental discovery that both cancer cell and stem cell growth are mediated by the same two molecules: the growth factor NME-p and the growth factor receptor MUC1*◆ Developed commercial strategy for the company's stem cell products◆ Collaborated on development and IND filing for cell therapy (CAR-T) portfolio◆ Established external partnerships and collaborations with industry thought leaders -
Chief Business Officer | Stem Cells & Regenerative MedicineOrig3N Sep 2014 - Jun 2016ORIG3N develops novel approaches for drug efficacy screening and human healthcare utilizing Induced Pluripotent Stem Cells (iPSCs). We deliver products and services to the healthcare marketplace as well as technologies for biotechnology and pharmaceutical research and development.◆ Responsible for ensuring the commercial success of ORIG3N's stem cell platform◆ Developed and executed the organization's product, sales, and partnership strategies ◆ Part of founding leadership team that raised $15.6M in venture capital
-
Associate Director, Product Management | Cell BiologyLife Technologies Feb 2014 - Sep 2014Waltham, Ma, Us- Thermo Fisher Scientific Acquired Life Technologies in Feb 2014 - Thermo Fisher Scientific is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable our customers to make the world healthier, cleaner and safer.Lead product management of a $70M+ global cell biology portfolio including the industry leading Lipofectamine® brand of transfection reagents. Developed product strategy and managed innovation pipeline.◆ Reversed portfolio decline and drove portfolio to back-to-back quarters of double digit growth ◆ Launched Lipofectamine 3000 - exceeded global forecast and Awarded 2014 “Marketing Excellence: Impact Award" -
Sr. Product Manager | Primary & Stem Cell SystemsLife Technologies Mar 2011 - Feb 2014Waltham, Ma, UsLife Technologies is a global biotechnology tools company dedicated to improving the human condition. The PSCS division provides innovative, biologically relevant systems that are representative of in vivo systems for major research and disease areas. Our products enable faster discovery and development of safer and more effective medicines.Lead product management for a portfolio of stem cell product including culture media and differentiation products. Responsible for alignment of strategies, resources and processes between Operations, R&D and Marketing functions◆ Developed and executed company's stem cell media strategy◆ Established collaborations with key opinion leaders in the stem cell space◆ Licensed and launched Essential 8 culture medium; exceeded revenue plan in ‘12 & ‘13◆ Launched products for the differentiation of pluripotent stem cells
-
Product Manager | In Vitro Adme/ToxLife Technologies Sep 2008 - Mar 2011Waltham, Ma, UsThe ADME/Tox division provides innovative cell-based products and services to accelerate the development of safe, effective drugs and ensure the safety of all types of chemical compounds. Through internal research and collaboration, we work to extend the utility, reproducibility, viability and predictability of hepatic and other in vitro models.
-
Senior Product Manager | Genotyping & Gene ExpressionCogenics Inc., A Division Of Clinical Data May 2006 - Sep 2008Us► Senior Product Manager (March 2008 - September 2008)► Product Manager (May 2006 - February 2008) Cogenics provides the broadest range of genomics services for both research and regulated projects, including services to support clinical trials, molecular diagnostics, pharmacogenomic discovery, validation, and biomarker research. Services include genotyping, sequencing, gene expression profiling, cell bank characterization, bioinformatics, DNA/RNA extraction, and biorepositories. -
Manager, Marketing & Business DevelopmentSynthonix Inc. Nov 2004 - May 2006Wake Forest, Nc, UsSynthonix specializes in the synthesis of small molecule heterocycles designed with biological and pharmacological bias. Synthonix offers powerful molecules tailored to participate in proven chemical reactions such as Horner-Wadsworth-Emmons coupling, Suzuki and Stille coupling, condensations, cycloadditions, and many others. -
Project Coordinator | Summit PharmaceuticalsSumitomo Corporation Of America 2002 - 2004New York, Ny, UsSummit Pharmaceuticals is a sourcing partner for major pharmaceutical corporations utilizing a global network of pharma experts and local market knowledge to offer the best solutions to save cost and time in drug development. Areas of expertise include sourcing of chemical intermediates, active pharmaceutical ingredients and development of new suppliers throughout the world for new chemicals.
James Lovgren Skills
James Lovgren Education Details
-
North Carolina State UniversityFinance -
University Of North FloridaBiology
-
Saïd Business School, University Of OxfordExecutive Strategy Program
-
The Wharton SchoolInnovation For Growth: Strategies And Best Practices
-
Uc IrvineIntegrated Marketing
-
University Of North Carolina At Chapel HillNegotiation Skills For Effective Managers
Frequently Asked Questions about James Lovgren
What company does James Lovgren work for?
James Lovgren works for Aspiro Therapeutics
What is James Lovgren's role at the current company?
James Lovgren's current role is Chief Executive Officer and Co-Founder.
What is James Lovgren's email address?
James Lovgren's email address is jl****@****hoo.com
What is James Lovgren's direct phone number?
James Lovgren's direct phone number is +161794*****
What schools did James Lovgren attend?
James Lovgren attended North Carolina State University, University Of North Florida, Saïd Business School, University Of Oxford, The Wharton School, Uc Irvine, University Of North Carolina At Chapel Hill.
What are some of James Lovgren's interests?
James Lovgren has interest in Football, Exercise, Home Improvement, Reading, Sports, Watching Basketball, Golf, Watching Sports, Cooking, Cruises.
What skills is James Lovgren known for?
James Lovgren has skills like Leadership, Product Marketing, Development, Marketing Management, Team Building, International Business, Strategic Partnerships, Brand Development, Genomics, Financial Modeling, Forecasting, Biotechnology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial